USPTO serial 79391198
GLYVAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 10, 2026
- Examiner
- LAW, CHRISTOPHER M
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with GLYVAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark E. Olds
Mark E. Olds Muncy, Geissler, Olds & Lowe, P.C.125 S Royal StreetAlexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes; chemical reagents for laboratory use, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical laboratory use, medical, or veterinary use; diagnostic preparations for scientific or research use; reagents for research purposes; reagents for scientific purposes; Diagnostic reagents for industrial purposes; Chemical reagents for industrial purposes; fluorescent chemical preparations for scientific purposes; Diagnostic reagents for laboratory purposes, other than for medical or veterinary purposes; Chemical reagents for laboratory purposes, other than for medical or veterinary purposes; bacterial preparations, other than for medical and veterinary use; bacteriological preparations, other than for medical and veterinary use; chemicals for use in scientific research, other than for medical or veterinary purposes; biochemical preparations for scientific purposes; biochemicals for in vitro and in vivo scientific use; biological tissue cultures, other than for medical or veterinary purposes; Diagnostic reagents for use with analyzers, other than for medical or veterinary purposes; Diagnostic reagents for use in analytical tests, other than for medical or veterinary purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic preparations, other than for medical or veterinary purposes; Diagnostic immunoassay reagents, other than for medical use; chemical reagents for use in genetic research; cultures of microorganisms, other than for medical and veterinary use; buffer solutions for use in analytical chemistry; radioactive elements for scientific purposes; reference standards being biochemical preparations for scientific use; chemically treated nonmedical test strips for diagnostic purposes; chemical test paper for use with assays; Chemical test paper for use with immunoassays; test paper, chemical; antibodies being reagents for scientific purposes, other than for medical or veterinary use; antibody reagents for scientific purposes; indicators being chemical preparations for scientific use; calibration fluids for nucleic acid analyzers and immunoassay analyzers; chemically treated nonmedical test strips for calibration of laboratory apparatus; calibration fluids for optical readers | ACTIVE | — |
| 005 | Diagnostic preparations for medical or veterinary purposes; diagnostic substances for medical use; diagnostic biomarker reagents for medical purposes; biological diagnostic reagents for veterinary use; biological reagents for medical use; diagnostic reagents for medical use; veterinary diagnostic reagents; diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; chemical reagents for medical or veterinary purposes; clinical diagnostic reagents for medical use; medical diagnostic test strips for testing bodily fluids; reagent paper for medical or veterinary purposes; reagents for medical use in connection with analyzers; Diagnostic reagents for veterinary use in connection with analyzers; medical diagnostic reagents and assays for testing of body fluids; reagents and media for medical and veterinary diagnostic purposes; reagents for medical use; immunoassay reagents for medical use | ACTIVE | — |
| 009 | Testing apparatus for testing biochemical agents not for medical purposes; diagnostic apparatus for analyzing nucleic acids, proteins, peptides or glycans, not for medical purposes; scientific research and laboratory apparatus, namely, optical readers with built-in dispensers, and optical readers with or without temperature control; laboratory apparatus and instruments, namely, microplates, fluid dispensers, incubators, and microplate shakers, automated laboratory equipment in the nature of laboratory robots, optical filters for laboratory analyzers and optical readers, the foregoing not for medical use; microplate readers; electronic nonmedical imaging devices for microplate imaging; electronic nonmedical imaging devices for immunoassay test strip imaging; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; nonmedical imaging devices for microplate imaging; nonmedical imaging devices for immunoassay test strip imaging; fluorescence photometers; luminescence analyzers, namely, luminescence photometers; nanoparticle size analysers; optical readers; downloadable and recordable computer software for monitoring and controlling laboratory apparatus and instruments; downloadable and recordable computer software for processing and reporting measurement results of optical readers, nucleic acid analyzers and immunoassay analyzers, and for carrying out result interpretation algorithms; downloadable and recordable computer software for laboratory analyzers and microplate readers for use in medical decision support systems; data processing equipment | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments for cancer diagnostics and for distinguishing cancer from benign diseases for diagnostic purposes; medical instruments for protein glycovariant testing; testing apparatus for medical purposes for testing biomarkers for cancer or benign diseases in bodily fluids; apparatus for carrying-out diagnostic tests for medical purposes for testing biomarkers for cancer or benign diseases in bodily fluids; diagnostic, examination, and monitoring equipment; diagnostic apparatus for medical purposes, namely, immunoassay processing and analysis apparatus, lectin binding processing and analysis apparatus; medical diagnostic testing instruments for testing biomarkers for cancer or benign diseases in bodily fluids; medical instruments for infectious disease testing; immunological analysers being medical diagnostic instruments for the analysis of bodily fluids; bodily fluids testing apparatus for medical purposes; medical diagnostic testing instruments for use in immunoassay procedure; diagnostic imaging apparatus for medical use; automated analyzers being medical diagnostic instruments for the analysis of body fluids; medical apparatus for tumour diagnosis | ACTIVE | — |
| 042 | Scientific research; industrial analysis and research services in the field of diagnostic preparations and biotechnology instrumentation; science and technology services, namely, research in the field of diagnostic assays; scientific laboratory services; analytical research laboratory services in the field of diagnostics; medical research laboratory services; research laboratory services in the field of immunoassay and lectin binding testing; medical research laboratory service, namely, preparation of immunohistological samples for analysis in research laboratories; medical research laboratory service, namely, preparation of biological samples for testing and analysis in research laboratories; platform as a service (PaaS) services featuring computer software platforms for processing and analyzing measurement results of optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; software as a service (SaaS) services featuring software for analyzing and reporting of measurement results from optical readers and immunoassay analyzers, and for carrying out diagnostic result interpretation algorithms; software development, programming and implementation; design and development of computer database software; consultancy services relating to quality control; engineering consultancy relating to testing; rental of laboratory apparatus and instruments; scientific research for medical purposes in the area of cancerous diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Uniogen Oy
- Other trademarks owned by Uniogen Oy
- Other trademarks owned by Uniogen Oy
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named GLYVAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 10, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 25, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 25, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 10, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 10, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 10, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 20, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 20, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 14, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 30, 2025 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 17, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 17, 2025 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 17, 2025 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 17, 2025 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 17, 2025 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 13, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 27, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 27, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 27, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 29, 2025 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 13, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 13, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| May 16, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 30, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 30, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 30, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 16, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 16, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 7, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 6, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 30, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 19, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |